SCHEMBL3849147

SCHEMBL3849147

Fc1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2-c2ccc3ncnc(-c4nnc(C5CC5)o4)c3c2)c(F)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 2/20 0.34
TNKS O95271 7/20 0.33
PARP2 Q9UGN5 6/20 0.33
PARP1 P09874 5/20 0.33
CAMKK1 Q8N5S9 1/20 0.32
CAMKK2 Q96RR4 1/20 0.32
CYP3A4 P08684 6/20 0.32
HPGD P15428 2/20 0.32
CYP1A2 P05177 5/20 0.31
TSHR P16473 5/20 0.31
CYP2C19 P33261 5/20 0.31
ALDH1A1 P00352 4/20 0.31
HIF1A Q16665 4/20 0.31
MEN1 O00255 3/20 0.31
LMNA P02545 3/20 0.31
KMT2A Q03164 3/20 0.31
CYP2D6 P10635 3/20 0.31
KDM4E B2RXH2 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MAPK1 P28482 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846013 0.83 MAPK14 (0.33) MAPK14CAMKK1CAMKK2CYP3A4HPGD
SCHEMBL3846674 0.80 MAPK14 (0.41) MAPK14LRRK2
SCHEMBL3853415 0.79 PIM1 (0.36) MAPK14TNKSPARP2PARP1CYP3A4
SCHEMBL3847727 0.77 PIK3CD (0.41) CYP3A4HPGDCYP1A2TSHRCYP2C19
SCHEMBL3850684 0.76 ALOX5AP (0.39) CAMKK1CAMKK2MAPK1MAP4K4
SCHEMBL3849627 0.76 ALOX5AP (0.35)
SCHEMBL3845615 0.75 MAP4K4 (0.33) CYP3A4HPGDCYP1A2TSHRCYP2C19
SCHEMBL3847768 0.75 MAP4K4 (0.32) MAP4K4
SCHEMBL3846708 0.74 PTGS1 (0.34) CYP3A4HPGDCYP1A2TSHRCYP2C19
SCHEMBL3846869 0.72 TGFBR1 (0.35) MAPK14HPGDCYP1A2CYP2C19MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed